Next Generation Sequencing Market Estimated to Experience a Hike in Growth by 2035



This report presents a detailed, data-driven analysis of the global Next Generation Sequencing Market Size, Share And Growth Trend Analysis Report By Region And Segmentation Forecasts (2026 - 2035) size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.



I recently came across a report by Roots Analysis that really put things into perspective. According to them, The next generation sequencing market size, valued at USD 8.6 billion in 2025, is projected to reach USD 9.8 billion in 2026 and USD 46.5 billion by 2035, with a 18.9% CAGR during the forecast period 2026 to 2035.



Market Segmentation



- Historical Trend: Since 2020

- Forecast Period: Till 2035

- Current Market Size: USD 9.8 Billion

- Market Size in 2035: USD 46.5 Billion

- CAGR (Till 2035): 18.9%

- Type of Component

• Consumables

• Services

• Instruments

- Type of NGS Technique

• Targeted Sequencing

• / Whole Exome Sequencing

• RNA Sequencing

• Other Techniques

- Type of Technology Used

• Sequencing by Synthesis Technology

• Ion Semiconductor Technology

• Nanopore Sequencing Technology

• Other Technologies

- Application Area

• Clinical Applications

• Research and Applied Applications

- Target Therapeutic Area

• Oncological Disorders

• Genetic Disorders

• Reproductive Disorders

• Other Therapeutic Areas

- Purpose

• Diagnosis

• Risk Assessment

• Presymptomatic Assessment

• Screening

• Other Purposes

- End Users

• Academic and Research Institutes

• Hospitals and Clinics

• Pharmaceutical and Biotechnology Companies

• Other End Users

- Geographical Regions

• North America

• Europe

• Asia-Pacific

• Middle East and North Africa

• Latin America

- Market in North America

• US

• Canada

- Market in Europe

• Germany

• France

• Italy

• Spain

• UK

• Rest of Europe

- Market in Asia-Pacific

• China

• India

• Japan

• South Korea

• Singapore

• Rest of Asia-Pacific

- Market in Middle East and North Africa

• Egypt

• Israel

• Saudi Arabia

• Rest of Middle East and North Africa

- Market in Latin America

• Brazil

• Argentina

• Rest of Latin America

- Key Next Generation Sequencing Companies Profiled

• Admera Health

• Applied Biological Materials

• BGI Genomics

• CD Genomics

• DNA Link

• Eurofins Genomics

• Gene by Gene

• GENEWIZ

• MedGenome

• Novogene

• Psomagen

• Veritas

• Xcelris Labs

- Key Next-generation Sequencing Technology Providers Profiled

• Illumina

• MGI Tech

• Oxford Nanopore Technologies

• Pacific Biosciences

• Thermo Fisher Scientific

- PowerPoint Presentation(Complimentary): Available

- Customization Scope: 15% Free Customization

- Excel Data Packs(Complimentary)

• Market Landscape (

• Market Landscape (

• Technologies / Platforms Competitive Analysis

• Patent Analysis

• Clinical Trial Analysis

• Big Pharma Analysis

• Case Study Analysis

• Market Forecast and Opportunity Analysis





Read More: https://www.rootsanalysis.com/reports/next-generation-sequencing/290.html



Key Geographies



North America

Europe

Asia-Pacific

Middle East and North Africa

Latin America

Each segment is analyzed by volume, value, and growth patterns, offering a comparative understanding of usage trends and market opportunities.



Next Generation Sequencing Market Share Insights

▪ Market Share by Type of Component

▪ Market Share by Type of NGS Technique

▪ Market Share by Type of Technology Used

▪ Market Share by Application Area

▪ Market Share by Target Therapeutic Area

▪ Market Share by Purpose

▪ Market Share by End Users

▪ Market Share by Geographical Regions







Analytical Insights Covered



▪ Market Landscape ( Service Providers )

▪ Market Landscape ( Technology / Platform Providers )

▪ Technologies / Platforms Competitive Analysis

▪ Patent Analysis

▪ Clinical Trial Analysis

▪ Big Pharma Analysis

▪ Case Study Analysis

▪ Market Forecast and Opportunity Analysis







Key Players Include:



Andermatt

Bayer

BioSafe Systems

Certis Biologicals

Corteva Agriscience

Novozymes

Nutri-Tech Solutions

ProFarm

Syngenta

Valent Biosciences

These companies are assessed based on their contributions to market share, innovation, and responsiveness to global and regional demand shifts.



Regional Insights



Each region is evaluated based on:



Historical market trends and sales data

Regulatory frameworks

Product availability and distribution strength

Emerging opportunities and constraints

Comparative regional analysis enables better targeting of expansion strategies and investment planning.



Supply Chain & Operational Overview



This section covers:



Pricing structures

Distribution channels

Manufacturing capabilities

Cost breakdowns and logistics trends

Understanding operational flows adds value to strategic sourcing and capacity expansion discussions.



Research Methodology



This report is developed using a combination of:



Primary research: Expert interviews, corporate disclosures

Secondary research: Company websites, public filings, databases, and published literature

All data points were reviewed for consistency, ensuring neutrality, reliability, and practical relevance for stakeholders and strategic planners.



Conclusion and Customization



This Next Generation Sequencing MarketSize, Share And Growth Trend Analysis Report By Region And Segmentation Forecasts (2026 - 2035) report serves as a foundational reference for:



Market entry and expansion strategies

Product development roadmaps

Investment decision-making

For custom data slices or tailored analysis by geography, product, or competitor, please contact sales@rootsanalysis.com.